Uses of Voritrol 200mg Tablet

Voritrol 200mg Tablet is used for the treatment or prevention of the following disease(s):

Fungal Infections

Side effects of Voritrol 200mg Tablet

Precautions while taking Voritrol 200mg Tablet

Dosage of Voritrol 200mg Tablet

Overdose of Voritrol 200mg Tablet

Onset of Action of Voritrol 200mg Tablet

Duration of Action of Voritrol 200mg Tablet

Precautions & Warnings


Information will be added soon.


Information will be added soon.


Information will be added soon.


Information will be added soon.


Information will be added soon.


Information will be added soon.

All substitutes for Voritrol 200mg Tablet

For information purpose only. Refer to a healthcare professionals before consuming any medicines and/or drugs.


Drug :- alfentanil: Increased plasma alfentanil level and increased risk of adverse reactions.

benzodiazepines: Possibly prolonged sedative effect of benzodiazepines.

calcium channel blockers, HMG-CoA reductase inhibitors, such as lovastatin, omeprazole, sirolimus: Possibly increased plasma levels of these drugs, leading to increased risk of adverse reactions and toxicity.

carbamazepine, long-acting barbiturates, phenytoin, rifampin: Decreased plasma voriconazole concentration.

coumarin, warfarin: Possibly increased PTT cyclosporine, sirolimus, tacrolimus: Increased serum concentrations of these drugs and risk of toxicity, especially nephrotoxicity.

CYP3A4 substrates astemizole, cisapride, pimozide, quinidine, terfenadine: Increased plasma levels of these drugs, which may lead to prolonged QT interval and, rarely, torsades de pointes.

ergot alkaloids ergotamine, dihydroergotamine: May increase plasma level of ergot alkaloids, leading to ergotism.

HIV protease inhibitors amprenavir, nelfinavir, ritonavir, saquinavir, non-nucleoside reverse transcriptase inhibitors delavirdine, efavirenz: Possibly inhibited metabolism of these drugs and voriconazole.

methadone: Increased plasma level of methadone, possibly leading to toxicity, including QT-interval prolongation.

oral contraceptives: Increased plasma voriconazole level and risk of toxicity.

rifabutin: Increased rifabutin plasma level, decreased voriconazole plasma level.

St. John's wort: Decreased plasma voriconazole level.

sulfonylureas: Possibly increased plasma level of sulfonylureas and increased risk of hypoglycemia.

vinca alkaloids: Possibly increased risk of neurotoxicity.

Kunal is a registered pharmacist with RGUHS with over 4 years experience. He is a medicine content contributor at